Mon, Dec 22, 2014, 7:54 AM EST - U.S. Markets open in 1 hr 36 mins


% | $
Quotes you view appear here for quick access.

Tekmira Pharmaceuticals Corp Message Board

  • rnai_inv rnai_inv Oct 9, 2012 6:23 AM Flag

    target price on Tekmira to $7.50

    "Byron Capital analyst Douglas Loe says the decision to lift the stop work order provides him with supporting evidence for Tekmira’s prospects. He points out that peer Sarepta Therapeutics (NASDAQ:SRPT )was also subjected to a stop-work order for its RNA-based Ebola drug, but announced its U.S. government contract had been terminated. Loe says he is now reincorporating projected revenue from the ebola contract into his financial model before the work stoppage was in place, and raising his target on the stock to $7.50 from his previous target of $5.25. Loe maintains a Speculative BUY rating on the stock. "

    SortNewest  |  Oldest  |  Most Replied Expand all replies
13.32-0.50(-3.62%)Dec 19 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.